
Sumanta Pal/X and Kelly Mahuron/X
Sep 2, 2025, 06:51
Sumanta Pal Discusses TIL Therapy’s Impact Beyond Melanoma With Kelly Mahuron
Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared a post on LinkedIn:
“There’s no doubt TIL therapy has had a tangible impact on melanoma, but the potential of this therapy does not end here. I sat down with City of Hope surgeon Kelly Mahuron to discuss the latest research in this space. Listen to the link below!”
More posts featuring Sumanta Pal on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 10:02
Sep 2, 2025, 09:56
Sep 2, 2025, 09:42
Sep 2, 2025, 09:40
Sep 2, 2025, 09:20
Sep 2, 2025, 09:11
Sep 2, 2025, 08:58
Sep 2, 2025, 08:42